Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that more inclusive research involving the transgender community is needed, especially on the neovaginal microbiome of trans women.

Australia needs better dermatological guidelines for gender-diverse patients.

Doctors are preparing to potentially perform uterus transplants in transgender women, considering technical, hormonal, and ethical factors.

Hormone therapy in transgender and gender diverse individuals affects hair loss differently than in cisgender individuals.

Transgender individuals face more barriers and less autonomy in surgical body modifications compared to cisgender individuals.

Denying transgender minors gender-affirming care, while allowing it for cisgender minors, is sex discrimination.

Progesterone may help trans women with breast development and health, but more research is needed.

Genetics may play a significant role in gender dysphoria.

Care for gender-dysphoric Veterans can be improved with a consistent, team-based approach.

Transgender men on testosterone therapy need ongoing gynecologic care due to potential cancer risks.

Surgeons must understand the full care process for gender confirmation surgery to help transgender individuals effectively.

Medical care for transgender youth should be individualized and supportive.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Testosterone therapy in transgender men has both desired effects like increased muscle mass and potential health risks such as higher cardiovascular risk.

The conclusion is that published guidelines are improving transgender medical care, but more research and education in transgender medicine are needed.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

5α-reductase deficiency can cause ambiguous genitalia and gender dysphoria, treatable with testosterone.

Facial hair is crucial for transgender men's gender identity and transition.

Parental support and gender-affirming care are crucial for the mental health of transgender adolescents.

The treatment helped a transgender woman stop drinking, improved her mental health, and reduced her gender dysphoria.

Oocyte retrieval is possible for transgender men on testosterone therapy without affecting fertility outcomes.

Transmasculine individuals on testosterone therapy need tailored contraception and fertility advice due to unique risks and benefits of each contraceptive method.

Most youth with gender dysphoria received hormones, had minor complications, and showed a decrease in suicide attempts after treatment.

Hormone therapy for trans individuals is effective and generally safe in the short term.

Individuals with this condition often develop male traits and identities at puberty despite being raised as females.

The discovery of 5α-reductase deficiency in guevedoces led to the development of important urologic medications.